• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND SARS-COV-2-IGG REAGENT KIT; REAGENT, CORONAVIRUS SEROLOGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND SARS-COV-2-IGG REAGENT KIT; REAGENT, CORONAVIRUS SEROLOGICAL Back to Search Results
Catalog Number 06R86-23
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/01/2022
Event Type  malfunction  
Manufacturer Narrative
Patient identifier: (b)(6).All available patient information is included.Additional patient details are not available.This report is being filed on an international product, list number 06r86-23 (sars-cov-2 igg reagent kit) that has a similar product distributed in the us, list number 06r86-20 /-30 (sars-cov-2 igg assay), eua (b)(4).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer was conducting a health screening for staff members.Out of the 415 patient samples tested, the customer observed false positive architect sars-cov-2 igg results for 9 samples while running on the architect i2000sr analyzer.The following results were provided (reference range: < 1.4 index is negative, >/= 1.4 index is positive): sid (b)(6): initial result: 1.71 index, repeat results: 0.05, 0.05 index.Sid (b)(6) : initial result: 2.48 index, repeat results: 0.03, 0.03 index.Sid (b)(6): initial result: 1.96 index, repeat results: 0.04, 0.04 index.Sid (b)(6): initial result: 1.58 index, repeat results: 0.77, 0.78 index.Sid (b)(6): initial result: 1.79 index, repeat results: 0.04, 0.03 index.Sid (b)(6): initial result: 1.73 index, repeat results: 0.06, 0.07 index.Sid (b)(6): initial result: 1.62 index, repeat results: 0.05, 0.05 index.Sid (b)(6): initial result: 1.57 index, repeat results: 0.03, 0.03 index.Sid (b)(6): initial result: 1.47 index, repeat results: 0.05, 0.05 index.There was no impact to patient management reported.
 
Manufacturer Narrative
The complaint investigation for false positive architect sars-cov-2 igg results included a search for similar complaints, and the review of complaint text, trending data, labeling, and device history records.Return testing was not performed as returns were not available.A ticket search by lot indicates that the reagent lot performs as expected for this product.Tracking and trending determined no related trends for the product and for the complaint issue.Clinical specificity and sensitivity testing was performed using an in-house retain kit of lot 33209fn00.All specifications were met indicating the lot is performing acceptably.The device history records were reviewed and did not identify any non-conformances, potential non-conformances, or deviations related to the likely cause lot number or related to the complaint.Labeling was reviewed and adequately addresses the issue under review.Based on the investigation, no systemic issue or product deficiency for architect sars-cov-2 igg reagent lot 33209fn00 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SARS-COV-2-IGG REAGENT KIT
Type of Device
REAGENT, CORONAVIRUS SEROLOGICAL
Manufacturer (Section D)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI  F91VY44
Manufacturer (Section G)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI   F91VY44
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
433331157
MDR Report Key13544409
MDR Text Key286585788
Report Number3008344661-2022-00011
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/16/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/17/2022
Device Catalogue Number06R86-23
Device Lot Number33209FN00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/04/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/01/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2K PROC MOD, 03M74-01, (B)(6).; ARC I2K PROC MOD, 03M74-01, (B)(6).
-
-